Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using Irrisept Solution to Prevent Infections After Spine Surgery

Official title: Impact of Prophylactic Use of Irrisept Irrigation System for Spinal Instrumentation

Run by Rhode Island Hospital · NCT06439953 · Data updated 2026-11-12

This study is testing if using Irrisept instead of regular saline can help prevent infections after spine surgery for adults with different spinal conditions.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorRhode Island Hospital
Academic / other
Locations1 site (Providence, Rhode Island)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedApril 2028
Study endsApril 2028
Registry record updatedAugust 14, 2026
Trial IDNCT06439953 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older undergoing spinal surgery for deformity, oncologic, degenerative, or traumatic conditions.

Probably not a fit

Patients with acute or chronic open wounds, ongoing infections, or allergies to vancomycin or chlorhexidine may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of Irrisept, a broad-spectrum antiseptic, for wound irrigation in patients undergoing spinal instrumentation surgery. The study aims to reduce post-operative complications such as surgical site infections and seroma formation by utilizing Irrisept instead of traditional saline mixed with vancomycin. By terminally sterilizing the wound bed and prosthetic devices, the trial seeks to minimize bacterial colonization and biofilm formation, which are common precursors to infection. Eligible participants include adults with various spinal conditions who are undergoing standard surgical procedures.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of infections and complications following spinal surgery, leading to better patient outcomes.

How similar studies have gone: While the use of antiseptic solutions in surgical settings is common, the specific application of Irrisept in spinal surgery is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 18+ years old
* Indications: deformity, oncologic, degenerative, trauma
* Standard layer-by-layer closure
* Locoregional flap-based closure

Exclusion Criteria:

* Acute/chronic open wounds (spine or non-spine)
* On-going non-spinal infection within 30 days of index operation
* Concurrent antibiotic use (for spine or non-spine infections)
* History of prior spinal infection
* Allergy to vancomycin or chlorhexidine
* Suspicion for osteomyelitis
* Other surgery within 90 days post-operatively fromm index
* Concurrent enrollment in other trial

Where it's running

  • Rhode Island Hospital
    Providence, Rhode Island, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.